request demo
Clairity logo

AI Image-based Risk Now Available in Luminary Risk

Now available in Luminary Risk:
Clairity Breast, the first and only FDA-authorized, AI image-based risk assessment for breast cancer.

discover more

AI Image-based Risk Now Available in Luminary Risk

Luminary Risk:
Breast Cancer Risk Assessment Software

Request demo
Request a demo
breast scan icon

NOW AVAILABLE

AI Image-based
Risk Assessment

Clairity Breast is the first and only FDA-authorized AI image-based breast cancer risk assessment.

Discover more
Luminary Risk Logo

Develop Your High-Risk Screening Program with Luminary Risk

Growing your high-risk screening program involves more than calculating scores. It requires a reliable method for identifying patients who need supplemental screening and ensuring they receive timely follow-up.

Luminary Risk makes this possible through built-in automations that optimize staff efficiency, accelerate early detection, and increase patient compliance.

NOW AVAILABLE

AI Image-based Risk Assessment

Enhance breast cancer risk assessment with Clairity Breast, the first and only FDA-authorized AI image-based risk model.

Traditional risk models rely heavily on self- reported data like family history, yet 85% of women diagnosed with breast cancer have no known risk factors.

Clairity Breast analyzes mammogram images to estimate a woman’s 5-year breast cancer risk, helping identify high-risk patients who may be missed by traditional models.

Now integrated with Luminary Risk, Clairity Breast enables imaging centers to identify, track, and manage elevated-risk patients— without disrupting existing workflows.

clairity logo
learn how clairity breast works
digital mammography machine is performing a stereotactic breast biopsy.

Download Our High-Risk Breast Screening Program Guide

Discover how more breast imaging centers are identifying high-risk patients, reducing manual efforts, and boosting supplemental screening revenue by:

  • Defining high-risk follow-up protocols, including referral processes for genetic testing
  • Deploying Tyrer-Cuzick v8 and integrating breast density assessment softwares
  • Increasing breast MRI volumes and patient follow-through
  • Selecting the right risk model for their population
  • Streamlining workflow to optimize staff productivity

Luminary Risk’s innovative automations save time, improve care, and drive program growth.

Download E-book

Tailor Breast Cancer Risk Assessment to Any Size Program

Organizations ranging from single-site breast imaging centers to multi-location health systems rely on Luminary Risk for tailored high-risk screening. The platform offers the flexibility to support programs of any size, streamlining workflows and adapting to your program as resources and needs evolve. The software seamlessly integrates with existing protocols, staffing models, and reporting needs.

Request a Demo

Streamlining Risk Assessment for High-Volume Imaging

Luminary Risk’s intuitive interface simplifies the process for both patients and staff, ensuring efficient and accurate risk stratification. By performing over a thousand risk assessments daily—including Tyrer-Cuzick scoring and comprehensive risk questionnaires—this platform allows us to identify women who may benefit from additional screening beyond a standard mammogram. MagView’s technology has been instrumental in delivering a truly personalized approach to breast cancer detection for our patients.
Man smiling Avatar
Dr. Sean Raj
Chief Innovation Officer, SimonMed Imaging

Integrate Automated Risk Scoring Into Clinical Workflows

EHRs often lack tools to systematically identify high-risk patients, leaving staff to rely on manual workarounds that are time-consuming and prone to errors. Luminary Risk integrates directly into your workflow, generating risk scores where and when you need them. It enables more confident clinical decision-making while reducing administrative burden.

Breast Cancer Report Chart image
women viewing tablet

Complete Tyrer-Cuzick Data Collection

Patients submit self-reported risk factor data online from home or via tablet in your waiting room. The intuitive interface of our Luminary Risk breast cancer risk assessment questionnaire collects all necessary inputs for the Tyrer-Cuzick v8.0 (IBIS) risk model. This method enhances data quality and ensures consistency across your high-risk screening program.

background circle image

Embed Breast Cancer Risk Scores Into the Reporting Process

After automatically calculating breast cancer risk scores, the software flags high-risk patients within the radiologist’s reporting platform. No separate systems or additional steps are required.

Embedding risk information into the reporting process helps prevent delays in decision-making, ensures risk-aligned follow-up, and preserves radiologist productivity. And, Luminary Risk provides options to integrate with breast density measurement software for risk calculation and density notification to patients and providers.

Breast Cancer Score Meter Chart image

Standardize Care Pathways Without Additional Work Steps

Luminary Risk delivers recommendations based on NCCN guidelines or your organization’s custom protocols. Patients meeting criteria for MRI, genetic counseling, or testing are flagged, with each recommendation documented to ensure follow-through. This step, along with integrations with genetic testing labs, supports standardized care pathways that require minimal staff intervention.

Automate Communications to Enhance Patient Experience and Engagement

By streamlining patient engagement, Luminary Risk helps imaging centers develop high-risk screening programs without adding complexity. Timely, personalized emails, letters, and text messages help patients and providers follow through on elevated risk findings. These follow-up tools support earlier interventions, lead to more positive outcomes, and boost patient return rates.

Magview Chat box image
National Accreditation Program for Breast Centers (NAPBC) logo

Enable NAPBC Compliance With Built-In Risk Protocols

Luminary Risk helps breast centers align with the 2024 National Accreditation Program for Breast Centers (NAPBC) standards. It operationalizes risk assessment protocol requirements for identifying and managing high-risk patients. The software’s structured, guideline-based approach also supports accreditation readiness.

Turn Breast Cancer Risk Stratification Into a Scalable Growth Driver

Ready to expand your high-risk screening program with ease and flexibility? Schedule a demo of Luminary Risk breast cancer risk assessment software. Discover how it fits into your workflow, supports stronger outcomes, and powers program advancement.
Request a Demo

Request A Demo

Request a Demo

Request a Demo

Breast cancer risk calculator